Group | Baseline | Week 1 | Week 2 | Week 4 | Week 6 | Week 8 |
---|
Placebo
| 3.4 ± 0.5 | 3.6 ± 0.5 | 3.1 ± 0.5 | 3.0 ± 0.5 | 2.6 ± 0.5 * | 2.4 ± 0.5 * |
A
| 3.5 ± 0.5 | 3.0 ± 0.5 * | 2.9 ± 0.6 * | 2.4 ± 0.5 ** | 2.4 ± 0.5 ** | 2.3 ± 0.5 ** |
B
| 3.3 ± 0.4 | 2.9 ± 0.5 * | 2.6 ± 0.5 ** | 2.1 ± 0.4 ** | 2.2 ± 0.5 ** | 1.9 ± 0.3 ** |
C
| 3.3 ± 0.4 | 3.2 ± 0.4 | 3.0 ± 0.4 | 2.1 ± 0.3 *** | 2.0 ± 0.3 *** | 1.6 ± 0.4 *** |
- Data expressed as mean ± sem. Group A = High dose sierrasil (n = 20), Group B = Low dose sierrasil (n = 21), Group C = Low dose sierrasil + cat's claw extract (n = 25), placebo n = 22. All groups displayed a significant change over the 8 weeks of the study (p < 0.001, ANOVA). Using the Wilcoxan Matched-Pairs Signed-Rank test the following descriptors reflect statistical significance from baseline; * p < 0.05, ** p < 0.01, *** p < 0.001.